Roivant Sciences (ROIV) Stock Forecast & Price Target

$28.82 +0.50 (+1.77%)

Closing price 04:00 PM Eastern

Extended Trading

$28.92 +0.09 (+0.33%)

As of 05:58 PM Eastern

Compare

Roivant Sciences - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
1

Hold
1

Buy
10

Based on 12 Wall Street analysts who have issued ratings for Roivant Sciences in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 1 has given a sell rating, 1 has given a hold rating, and 10 have given a buy rating for ROIV.

Consensus Price Target

$30.55
6.00% Upside

According to the 12 analysts' twelve-month price targets for Roivant Sciences, the average price target is $30.55. The highest price target for ROIV is $40.00, while the lowest price target for ROIV is $16.50. The average price target represents a forecasted upside of 6.00% from the current price of $28.82.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ROIV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Roivant Sciences and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ROIV Analyst Ratings Over Time

Type	Current Forecast 5/6/25 to 5/6/26	1 Month Ago 4/6/25 to 4/6/26	3 Months Ago 2/5/25 to 2/5/26	1 Year Ago 5/6/24 to 5/6/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	10 Buy rating(s)	9 Buy rating(s)	7 Buy rating(s)	2 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$30.55	$29.50	$25.19	$17.50
Forecasted Upside	6.00% Upside	5.81% Upside	19.15% Upside	58.23% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

ROIV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ROIV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Roivant Sciences Stock vs. The Competition

Type	Roivant Sciences	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	7.87% Upside	938.12% Upside	14.75% Upside
News Sentiment Rating	Positive News See Recent ROIV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
4/16/2026	Piper Sandler 2 of 5 stars	Yasmeen Rahimi 5 of 5 stars	Boost Target	Overweight	$22.00 ➝ $40.00	+36.65%
3/20/2026	Sanford C. Bernstein 4 of 5 stars		Initiated Coverage	Outperform	$35.00	+25.90%
3/4/2026	TD Cowen 3 of 5 stars		Reiterated Rating	Buy
3/4/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$33.00 ➝ $34.00	+22.08%
3/3/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dennis Ding Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
2/10/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samantha Semenkow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$26.00 ➝ $35.00	+26.49%
2/9/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C-) ➝ Sell (D)
2/9/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yastin Suneja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$28.00 ➝ $30.00	+16.01%
12/15/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Risinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$29.00 ➝ $32.00	+44.80%
12/15/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Corinne Jenkins Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$24.00 ➝ $33.00	+50.79%
Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.
9/18/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$16.00 ➝ $20.00	+29.72%
9/18/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chi Fong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$12.00 ➝ $16.50	+7.98%
3/4/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Prakhar Agrawal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:03 PM ET.

ROIV Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Roivant Sciences is $30.55, with a high forecast of $40.00 and a low forecast of $16.50.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Roivant Sciences in the last twelve months. There is currently 1 sell rating, 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ROIV shares.
: According to analysts, Roivant Sciences's stock has a predicted upside of 6.00% based on their 12-month stock forecasts.
: Over the previous 90 days, Roivant Sciences's stock had 1 downgrade by analysts.
: Roivant Sciences has been rated by research analysts at Citigroup, Guggenheim, HC Wainwright, Jefferies Financial Group, Piper Sandler, Sanford C. Bernstein, TD Cowen, and Weiss Ratings in the past 90 days.
: Analysts like Roivant Sciences more than other "medical" companies. The consensus rating for Roivant Sciences is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ROIV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roivant Sciences Recommendations

This page (NASDAQ:ROIV) was last updated on 5/6/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Roivant Sciences (ROIV) Stock Forecast & Price Target

Roivant Sciences - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ROIV Analyst Ratings Over Time

ROIV Analyst Recommendations By Month

ROIV Price Targets by Month

Roivant Sciences Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

ROIV Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roivant Sciences Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Roivant Sciences (ROIV) Stock Forecast & Price Target

Roivant Sciences - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

ROIV Analyst Ratings Over Time

ROIV Analyst Recommendations By Month

ROIV Price Targets by Month

Roivant Sciences Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

ROIV Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Roivant Sciences Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools